Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GM2 (ganglioside) is a glycosphingolipid primarily found in neuronal cell membranes. It plays roles in cell signaling, neuronal development, and immune responses. Its accumulation due to genetic defects in catabolic enzymes leads to severe neurodegenerative disorders called GM2 gangliosidoses (e.g., Tay-Sachs, Sandhoff). GM2 is also expressed on some cancer cells, making it a target for antibody-based immunotherapies.
Antibody-mediated cell death/inhibition of metastasis (for anti-GM2 antibodies)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GM2 (Ganglioside).